The Australian College of Pharmacy has released five new CPD activities, available to all Australian pharmacists at no cost. Developed by ACP, the modules are supported by an unrestricted grant from Bayer Australia. The CPD activities cover five OTC areas, with the titles of the interactive online modules being: Women’s …
Read More »Green light for proposed acquisition
The ACCC will not oppose GSK’s proposed acquisition of Pfizer’s consumer healthcare business in Australia. GSK and Pfizer supply prescription and over-the-counter medications including the well-known pain management products Panadol, Voltaren and Advil, as well as gastrointestinal and cold and flu products. The proposed acquisition combines only their over-the-counter businesses. …
Read More »AFT gross profit up 32pc
AFT Pharmaceuticals’ gross profit for the year ended March 31, 2018 (FY2018) increased by 32 per cent to $34.2 million, according to its full-year audited financial results. Performance highlights include: Total income increased 16 per cent to $81.9 – comprising operating revenues of $80.1 million (previous corresponding period $69.2 million) and …
Read More »Arrow and Apotex Australia to merge
Arrow Pharmaceuticals and Apotex have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations. The proposed merger, still subject to several conditions, including ACCC approval and due diligence, aims to create a sustainable platform for growth and development of the companies’ business interests in …
Read More »